IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management, LLC

Q1 2015 Holdings

Filed 2015-05-14 | 26 holdings | $25.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$15.8M1,744,35661.4%
Coherus Biosciences Inc(CHRS)COM19249H103$7.9M870,26931.0%
Ascendis Pharma A/S(ASND)COM04351P101$1.6M811,1526.1%
Juno Therapeutics IncCOM48205A109$97.0K1,749,9990.4%
Anacor Pharmaceuticals IncCOM032420101$68.2K1,178,4740.3%
Avalanche Biotechnologies IncCOM05337G107$56.0K1,382,7350.2%
DBV TechnologiesCOMF2927N109$29.6K693,8100.1%
GW PharmaceuticalsCOM36197T103$28.4K311,8530.1%
Zafgen IncCOM98885E103$21.4K541,4800.1%
Dyax CorpCOM26746E103$16.8K1,000,6590.1%
Heron Therapeutics Inc(HRTX)COM427746102$15.9K1,095,7340.1%
Flamel Technologies S.A.COM338488109$9.0K500,0000.0%
Alcobra LtdCOMM2239P109$8.4K1,500,0000.0%
Stemline Therapeutics IncCOM85858C107$6.5K451,4000.0%
TherapeuticsMD IncCOM88338N107$5.1K846,5000.0%
Cynapsus Therapeutics IncCOM23257Y701$5.1K5,878,8550.0%
Lipocine IncCOM53630X104$4.6K669,9210.0%
ZS Pharma IncCOM98979G105$4.2K100,0000.0%
Ocera TherapeuticsCOM67552A108$3.3K703,7300.0%